Education and support program for African American patients with advanced kidney disease
Intensive Patient Referral and Education Program Prior to Renal Replacement Therapy
NA · University of Chicago · NCT06397456
This study is testing a 12-week education and support program for African American patients with advanced kidney disease to see if it helps them better manage their condition and plan for treatment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Chicago (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06397456 on ClinicalTrials.gov |
What this trial studies
The Intensive Patient Referral and Education Program prior to Renal Replacement Therapy (iPREP-RRT) is a 12-week intervention designed for hospitalized African Americans with advanced chronic kidney disease (CKD). This program provides hospital- and community-based education, navigation, and self-management support to improve patient knowledge and self-efficacy regarding CKD and renal replacement therapy (RRT) planning. Participants will be randomized to receive either the iPREP-RRT intervention or enhanced usual care, with the aim of enhancing CKD self-management and RRT planning through various communication methods. The study evaluates the effectiveness of both hospital-based and community-based interventions in improving patient outcomes.
Who should consider this trial
Good fit: Ideal candidates are hospitalized African American patients aged 18 to 70 with advanced CKD (Stage 3B or above).
Not a fit: Patients who are non-English speaking, unable to communicate due to their medical status, or currently admitted to the ICU may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly enhance the self-management and treatment planning for African American patients with advanced CKD.
How similar studies have performed: Other studies have shown success with similar educational and support interventions for chronic disease management, indicating potential for positive outcomes in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 18 and under 70 * Admitted to the University of Chicago inpatient general medicine service * Likely hospital stay greater than 48 hours * Diagnosis of advanced CKD (Stage 3B or above, as determine by problem list, ICD- 10 codes or eGFR\<45 during admission and from previous medical encounters) * Self-identify as Black or African American Exclusion Criteria: * Non-English speaking * Unable to communicate due to current medical status * Unable to consent due to mental status * Expected hospital stay less than 24 hour * Current admission in ICU
Where this trial is running
Chicago, Illinois
- University of Chicago Medical Center — Chicago, Illinois, United States (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Disease, Hypertension, Hospitalized Patients, African American, Motivational Interviewing